Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
CNS & Neurological Disorders Drug Targets|January 26, 2026
Therapeutic Potential of Nutritional Modulators in Traumatic Brain Injury: A Systematic ReviewRomanpreet Kaur, Shamsher SinghPhysiology & Behavior|June 13, 2026
Epilepsy Associated Cognitive Dysfunction and Addiction: Possible Mechanisms and Clinical ChallengesAnshul, Romanpreet Kaur, Shamsher SinghMetabolic Brain Disease|March 20, 2025
Protective mechanism of apigenin in proton pump inhibitor-associated progressive cognitive impairment in adult zebrafish via targeting GSK-3β pathwayAnjalee Bhratee, Dhrita Chatterjee, Romanpreet Kaur, et al.Neuroscience Letters|June 4, 2026
Luteolin attenuates tramadol-induced parkinsonism-like toxicity by modulating neurotransmitters, neuroinflammation, and GSK-3β signaling in ratsNileshwar Kalia, Sourav Kumar Barik, Romanpreet Kaur, et al.Assay and Drug Development Technologies|March 17, 2025
Pharmacological Evaluation of Aescin for Neuroprotection in Intracerebroventricular Streptozotocin Model of Alzheimer's Disease in Experimental RatsShaveta Bhardwaj, Anu Jindal, Shamsher Singh, et al.Current Protein & Peptide Science|October 23, 2025
Therapeutic Horizons for Parkinson's Disease: Current Relevance of PNA5 in Memory and CognitionKousik Maparu, Dhrita Chatterjee, Nileshwar Kalia, et al.Medical Oncology (Northwood, London, England)|March 23, 2025
Molecular crosstalk between GPCR and receptor tyrosine-protein kinase in neuroblastoma: molecular mechanism and therapeutic implicationsKousik Maparu, Dhrita Chatterjee, Romanpreet Kaur, et al.Fitoterapia|December 14, 2025
Decoding the mechanistic landscape of harpagoside: From molecular targets to translational pharmacologyHarpreet Kaur, Dinesh Kumar, Vinod Kumar Gauttam, et al.Pageof 1